| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Argireline |
阿基瑞林 |
616204-22-9 |
詳細
|
| Rosuvastatin methyl ester |
瑞舒伐他汀甲酯. |
147118-40-9 |
詳細
|
| Methyl 4'-bromomethyl biphenyl-2-carboxylate |
4'-溴甲基-2-甲酸甲酯聯(lián)苯 |
114772-38-2 |
詳細
|
| Ethyl 4-(1-hydroxy-1-methyl-ethyl)-2-propyl-
imidazole-5-
carboxylate |
4-(1-羥基-1-甲基乙基)-2-丙基-1H-咪唑-5-羧酸乙酯 |
144689-93-0 |
詳細
|
| 4-Chloromethyl-5-
meth-yl-1,3-dioxol-
2-one |
4-氯甲基-5-甲基-1,3-二氧雜環(huán)戊烯-2-酮 |
80841-78-7 |
詳細
|
| 2-n-Propyl-4-methyl-6-(1-methylbenzimi-
dazole-2-yl)benz-
imidazole |
2-正丙基-4-甲基-6-(1'-甲基苯并咪唑-2-基)苯并咪唑 |
152628-02-9 |
詳細
|
| Rabamipide Na |
瑞巴派特鈉 |
|
詳細
|
| Dantrolene free base |
丹曲林 |
85008-71-5 |
詳細
|
| Dapoxetine free base |
達泊西汀 |
119356-77-3 |
詳細
|
| N-(4-cyanophenyl)-
glycine |
N-(4-氰基苯基)甘氨酸 |
42288-26-6 |
詳細
|
| Tadanafil P-1 |
(1R,3R)-1-(1,3-苯并二氧戊環(huán)-5-基)-2-(氯乙酰基)-2,3,4,9-四氫-1H-吡啶并[3,4-B]吲哚-3-羧酸甲酯 |
171489-59-1 |
詳細
|
| Varenicline free base |
伐倫克林游離堿 |
249296-44-4 |
詳細
|
| Valsartan methyl ester |
纈沙坦甲酯 |
137863-17-3 |
詳細
|
| Silodocin P-1 oxalate |
西洛多辛氰基物草酸鹽 |
|
詳細
|
| (S)-3-(methoxymetho-xy)-2,3-dimethylbutan-1-ol |
(S)-3 –(甲氧基甲基)-2,3 –二甲基丁- 1 - 醇 |
1217719-34-0 |
詳細
|
| ATB-1 |
2-氟-4-甲氧基-1-異丙基苯 |
1262414-96-9 |
詳細
|
| (R)-(2,3-dimethyl-3-
butyl)diphenyl
phosphineoxide |
(R)?-(3 -(甲氧基甲氧基)-2,3 -二甲基丁基)二苯基氧化膦 |
|
詳細
|
| Ethyl N-[3-amino-4-(methylamino)benzoyl]-N-
pyridin-2-yl-beta-
alaninate |
N-[4-甲胺基-3-氨基苯?；鵠-N-2-吡啶基- -丙氨酸乙酯 |
212322-56-0 |
詳細
|
| 5,6-Dihydroxy-1H-Indole-2-Carboxylic Acid |
5,6-二羥基-1H-吲哚-2-羧酸 |
4790-08-3 |
詳細
|
| (2S)-2-((1R,3aR,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol |
(2S)-2 – ((1R,3aR,7aR)-4 – ((叔丁基二甲基甲硅烷基)氧基)-7a-甲基八氫-1H-茚-1-基)丙-1-醇 |
215509-33-4 |
詳細
|
| (1R,3aR,7aR)-1-((2R,5S,E)-6-(methoxy
methoxy)-5,6-dimethylhept-3-en-2-yl)-7a-
methylhexahydro- 1H-inden-4(2H)-one |
(1R,3aR,7aR)-八氫-1-[(1R,2E,?4S)-5-(甲氧基甲氧基)-1,4,5-三甲基-2-己烯-1-基]-7a-甲基-4氫-茚-4-酮 |
100858-26-2 |
詳細
|
| 2-((3R,5R)-3,5-bis((
tert-butyldimethyl
silyl)-oxy) cyclohexylidene)
ethanol |
2-(3R,5R)-3,5 - 雙((叔丁基二甲基甲硅烷基)氧基)亞環(huán)己基)乙醇 |
139356-37-9 |
詳細
|
| ATB-4 |
2-氯-5-(三氟甲基)芐基溴 |
237761-77-2 |
詳細
|
| Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1-
methyl-1H-benz-
imidazol-5-yl)-
carbonyl]-N-pyridin-
2-yl-beta-alaninate |
3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯 |
211915-84-3 |
詳細
|
| (2-((3R,5R)-3,5-bis((
tert-butyldimethyl-
silyl)oxy)cyclohexyl-
idene)ethyl)diphenylphosphine oxide |
(2 –((3R, 5R)-3,5 - 雙((叔丁基二甲基甲硅烷基)氧基)亞環(huán)己基)乙基)二苯基氧化膦 |
139356-39-1 |
詳細
|
| 5,6-Dihydroxyindole |
5,6-二羥基吲哚 |
3131-52-0 |
詳細
|
| (R)-(2,3-dimethyl-3-((
triethylsilyl)
oxy)butyl)-
diphenylphosphine oxide |
(R)?-(2,3 - 二甲基-3 -((三乙基甲硅烷基)氧基)丁基)二苯基氧化膦 |
1227926-70-6 |
詳細
|
| (1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methyl hexahydro-1H- inden-4(2H)-one |
(1R,3aR,7aR)-1-((2R,5S,E)-5,6-二甲基-6-?(三乙基硅氧基) 庚烷-3-烯-2-基)-7a- 甲基六氫-1氫-茚 4(2氫)-酮 |
950586-26-2 |
詳細
|
| Diallyl bisphenol A |
2,2'-二烯丙基雙酚 |
1745-89-7 |
詳細
|
| (S)-2,3-Dimethyl-3-((
triethylsilyl)oxy)butan-1-ol |
(S)-2,3 - 二甲基-3 –((三乙基甲硅烷基)氧基)丁-1 - 醇 |
957997-83-0 |
詳細
|
| Erdosteine |
厄多司坦 |
84611-23-4 |
詳細
|
| Ilaprazole impurity 4 |
艾普拉唑雜質(zhì) 4 |
1018229-53-2 |
詳細
|
| Crisaborole impurity 3 |
克立硼羅雜質(zhì) 3 |
888967-63-3 |
詳細
|
| Ilaprazole impurity 3 |
艾普拉唑雜質(zhì) 3 |
84445-90-9 |
詳細
|
| (E)-methyl 3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)acrylate |
(E)-甲基-3-(2,2-甲基苯并[d][1,3]二氧基-5基-丙烯酸酯 |
2187481-85-0 |
詳細
|
| Sitagliptin impurity 3 |
西格列汀雜質(zhì) 3 |
823817-58-9 |
詳細
|
| Lesinurad sodium |
雷西納德鈉 |
1151516-14-1 |
詳細
|
| Sitagliptin impurity 1~5 |
Sitagliptin related substance西格列汀相關物質(zhì) |
|
詳細
|
| Phenethyl caffeate |
咖啡酸苯乙酯 |
104594-70-9 |
詳細
|
| Roxatidine impurity 3 |
羅沙替丁雜質(zhì) 3 |
78274-00-7 |
詳細
|
| Ilaprazole intermediate P-3 |
艾普拉唑中間體P-3 |
172152-53-3 |
詳細
|
| Silodosin P-1 oxalate |
西洛多辛P-1草酸鹽 |
1883697-83-3 |
詳細
|
| Benserazide HCl |
鹽酸芐絲肼 |
14919-77-8 |
詳細
|
| Roxatidine impurity 4 |
羅沙替丁雜質(zhì) 4 |
97900-87-3 |
詳細
|
| Benserazide P-1 |
芐絲肼 P-1 |
1353749-74-2 |
詳細
|
| Cis-Sertraline-D-Madenlic acid |
Sertraline HCl related substance舍曲林相關物質(zhì) |
|
詳細
|
| Ilaprazole impurity 1 |
艾普拉唑雜質(zhì) 1 |
172152-37-3 |
詳細
|
| N-Bn Tegoprazan parent nucleus |
N-芐基特戈拉贊母核 |
1640981-20-9 |
詳細
|
| Fexuprazan P-1 |
非蘇拉贊 P-1 |
1902955-31-0 |
詳細
|
| Ilaprazole |
艾普拉唑 |
172152-36-2 |
詳細
|
| Quinic acid |
右旋奎寧酸 |
77-95-2 |
詳細
|
| Methyl 5,6-dihydroxy-1H-indole-2-Carboxylate |
5,6-二羥基-1H-吲哚-2-羧酸甲酯 |
10131-14-3 |
詳細
|
| Caffeic acid |
咖啡酸 |
331-39-5 |
詳細
|
| Sitagliptin impurity 1 |
西格列汀雜質(zhì) 1 |
1345822-87-8 |
詳細
|
| Roxatidine impurity 1 |
羅沙替丁雜質(zhì) 1 |
73279-04-6 |
詳細
|
| Crisaborole impurity 2 |
克立硼羅雜質(zhì) 2 |
1187188-59-5 |
詳細
|
| Methyl caffeate |
咖啡酸甲酯 |
67667-67-8 |
詳細
|
| 2,2-dimethyl-5H-1,3-dioxol[4,5-f]indole |
2,2-二甲基- 5H-[1,3]-二惡英[4,5-f]吲哚 |
437757-21-6 |
詳細
|
| ATB-9 |
安塞曲匹中間體 |
875444-10-3 |
詳細
|
| Sitagliptin impurity 2 |
西格列汀雜質(zhì) 2 |
1345822-86-7 |
詳細
|
| de-bromo Lesinurad |
雷西納德脫溴雜質(zhì) |
1533519-93-5 |
詳細
|
| Fexuprazan P-4 |
非蘇拉贊 P-4 |
1902955-29-6 |
詳細
|
| N-Ts Tegoprazan P-1 |
N-對甲苯磺酰基特戈拉贊 P-1 |
4942485-42-9 |
詳細
|
| SPH4336 |
|
2765997-88-2 |
詳細
|
| (4-isobutoxyphenyl)methanol |
|
500547-59-1 |
詳細
|
| 1-(2-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea |
|
|
詳細
|
| Plazomicin impurity PLZA000017 |
普拉米星雜質(zhì) PLZA000017 |
|
詳細
|
| (E)-6,6'-(triaz-1-ene-1,3-diylbis(4,1-phenylene))bis(5-methyl-4,5-dihydropyridazin-3(2H)-one) |
|
1643436-59-1 |
詳細
|
| BI-6727 intermediate |
BI-6727的側(cè)鏈中間體 |
882660-39-1 |
詳細
|
| N,N'-((1S,2S)-cyclohexane-1,2-diyl)bis(N-methylpicolinamide) |
|
474937-35-4 |
詳細
|
| Asundexian intermediate |
Asundexian中間體 |
2376389-33-0 |
詳細
|
| Lansoprazole Enteric pellet |
蘭索拉唑腸溶微丸 |
|
詳細
|
| SPH3127 impurity G |
SPH3127雜質(zhì)G |
|
詳細
|
| 4-Isobutoxybenzyl (4-isobutoxybenzyl)carbamate |
|
|
詳細
|
| 5-(2-(benzyl(tert-butyl)amino)acetyl)-2-hydroxybenzyl acetate |
鹽酸左沙丁胺醇中間體I雜質(zhì)D |
|
詳細
|
| Pradofloxacin |
普多沙星 |
195532-12-8 |
詳細
|
| Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2S,2′S)-, ) |
（1R,1’R,2S,2’S）反-反異構(gòu)體
陽離子形態(tài) |
96946-45-1 |
詳細
|
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2,2-dimethyl-, iodide (1:1), (1R)- |
|
41431-32-7 |
詳細
|
| Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2R,2′S)-, benzenesulfonate (1:2) |
順反異構(gòu)體二苯磺酸鹽 |
96946-44-0 |
詳細
|
| 2-chloro-6-methylnicotinonitrile |
|
28900-10-9 |
詳細
|
| Plazomicin sulfate |
硫酸普拉米星 |
1380078-95-4 |
詳細
|
| tert-butyl (R)-3-(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propanoate free base |
苯磺順阿曲庫銨中間體Ⅱ游離態(tài) |
1075726-70-3 |
詳細
|
| Glimepiride methyl ester |
格列美脲甲基酯雜質(zhì) |
119018-30-3 |
詳細
|
| Plazomicin impurity PLZA000002 |
普拉米星雜質(zhì) PLZA000002 |
1154758-54-9 |
詳細
|
| Oseltamivir degradation impurity 1 |
奧司他韋降解雜質(zhì) 1 |
|
詳細
|
| Diclofenac Epolamine impurity 6 |
雙氯芬酸依泊胺雜質(zhì) 6 |
42088-52-8 |
詳細
|
| QBH-196-G;N-[3-fluoro-4-[[6-methoxy-7-[3-(4-methyl-1-piperidinyl)propoxy]-4-quinolinyl]oxy]phenyl]- Hydrazinecarboxamide |
|
1449763-35-2 |
詳細
|
| HPK1-IN-7 |
|
2320462-65-3 |
詳細
|
| Asundexian intermediate |
Asundexian中間體 |
2376389-34-1 |
詳細
|
| Plogosertib (CYC140) |
|
1137212-79-3 |
詳細
|
| N-Bn Tegoprazan P-1 |
N-芐基特戈拉贊 P-1 |
|
詳細
|
| 1H-Indole-3-carboxylic acid, 6-bromo-5-hydroxy-4-(1H-imidazol-1-ylmethyl)-1-methyl-2-[(phenylsulfinyl)methyl]-, ethyl ester; |
艾米朵爾 |
865171-50-2 |
詳細
|
| 2-(benzyl(tert-butyl)amino)-1-(4-(2-(4-hydroxy-3-(hydroxymethyl)phenyl)-2-oxoethoxy)-3-(hydroxymethyl)phenyl)ethan-1-one |
|
|
詳細
|
| Plazomicin impurity PLZA000029 |
普拉米星雜質(zhì)PLZA000029 |
|
詳細
|
| Orbifloxacin |
奧比沙星 |
113617-63-3 |
詳細
|
| Pimavanserin Tartrate |
酒石酸匹莫范色林;酒石酸哌馬色林 |
706782-28-7 |
詳細
|
| Plazomicin |
普拉米星 |
1154757-24-0 |
詳細
|
| Vonoprazan Fumarate |
富馬酸沃諾拉贊 |
1260141-27-2 |
詳細
|
| ((1R,2R)-2-(3-(tert-butoxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium ) |
順阿曲庫銨中間體Ⅲ R，R’-順酯陽離子形態(tài) |
1075726-99-6 |
詳細
|
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2,2-dimethyl-, iodide (1:1), (1R)- |
（R)-N-甲基-勞丹堿陽離子形態(tài) |
732929-47-4 |
詳細
|
| 1-(4-(3-Chloropropoxy)-5-methoxy-2-nitrophenyl)ethanone |
|
1160707-44-7 |
詳細
|
| 3-iodo-6-methyl-1H-pyrazolo[3,4-b]pyridine |
|
1352396-72-5 |
詳細
|
| MRX-I |
|
1112968-42-9 |
詳細
|
| Duloxetin HCl Enteric pellet |
鹽酸度洛西汀腸溶微丸 |
|
詳細
|
| Oseltamivir degradation impurity 2 |
奧司他韋降解雜質(zhì) 2 |
|
詳細
|
| Tamsulosin HCl Sustained-release pellet |
鹽酸坦索羅辛緩釋微丸 |
|
詳細
|
| Pancreatin |
胰酶 |
8049-47-6 |
詳細
|
| Raloxifene impurity 1 |
雷洛昔芬雜質(zhì) 1 |
84541-37-7 |
詳細
|
| Grape Leaf Extract |
葡萄葉提取物 |
|
詳細
|
| Pranoprofen P-2 |
普拉洛芬 P-2 |
146330-68-9 |
詳細
|
| Pranoprofen impurity B |
普拉洛芬雜質(zhì)B |
52549-22-1 |
詳細
|
| Liver Extract Anti-toxic Fraction |
牛肝提取物 |
|
詳細
|
| Deoxycholic acid impurity 3 |
去氧膽酸雜質(zhì) 4 |
|
詳細
|
| Roxatidine Acetate HCl Sustained-release pellet |
鹽酸羅沙替丁醋酸酯緩釋微丸 |
|
詳細
|
| Diclofenac Epolamine impurity 2 |
雙氯芬酸依泊胺雜質(zhì) 2 |
13625-57-5 |
詳細
|
| Deoxycholic acid impurity 2 |
去氧膽酸雜質(zhì) 2 |
|
詳細
|
| R-Tegoprazan isomer |
R-特戈拉贊異構(gòu)體 |
942195-56-4 |
詳細
|
| Omeprazole Enteric pellet |
奧美拉唑腸溶微丸 |
|
詳細
|
| Glimepiride Cis isomer |
格列美脲順勢異構(gòu)體 |
684286-46-2 |
詳細
|
| Sodium Picosulfate impurity A |
匹可硫酸鈉雜質(zhì)A |
32500-19-9 |
詳細
|
| Diclofenac Epolamine impurity 4 |
雙氯芬酸依泊胺雜質(zhì) 4 |
127792-23-8 |
詳細
|
| Deoxycholic acid impurity 1 |
去氧膽酸雜質(zhì) 1 |
|
詳細
|
| Deoxycholic acid P-1 |
去氧膽酸 P-1 |
181270-68-8 |
詳細
|
| Raloxifene impurity 2 |
雷洛昔芬雜質(zhì) 2 |
173773-26-7 |
詳細
|
| Raloxifene HCl P-1 |
甲基雷洛昔芬 |
84541-36-6 |
詳細
|
| Diclofenac Epolamine impurity 7 |
雙氯芬酸依泊胺雜質(zhì) 7 |
172494-87-0 |
詳細
|
| Plazomicin intermediate PLZA000006 |
普拉米星中間體PLZA000006 |
1154758-63-0 |
詳細
|
| 1,1-bis(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
|
2518374-84-8 |
詳細
|
| Cycloheptatriene |
環(huán)庚三烯 |
544-25-2 |
詳細
|
| bis(4-isobutoxybenzyl)amine hydrochloride |
|
2514955-85-0 |
詳細
|
| SPH5030-SM3
(R,Z)-2-fluoro-3-(1-methylpyrrolidin-2-yl)acrylic acid hydrochloride |
SPH5030 鹽酸鹽 |
2761913-41-9 |
詳細
|
| methyl 4-(trifluoromethyl)benzoate； |
4-三氟甲基苯甲酸甲酯 |
2967-66-0 |
詳細
|
| sEH/AChE inhibitor |
sEH/AChE雙靶點抑制劑 |
2490589-10-9 |
詳細
|
| SPH3127 impurity I |
SPH3127雜質(zhì)I |
|
詳細
|
| Deuterium I031-D |
氘代I031-D |
|
詳細
|
| 6-methyl-1H-pyrazolo[3,4-b]pyridin-3-amine |
|
79173-38-9 |
詳細
|
| ANC |
|
1149333-40-3 |
詳細
|
| CS-2064 |
|
1333146-24-9 |
詳細
|
| ethyl 4-(trifluoromethyl)；
Benzoate |
3-(三氟甲基)苯甲酸乙酯 |
76783-59-0 |
詳細
|
| PCB |
|
1231930-43-0 |
詳細
|